Clinical Laserthermia Systems AB (publ) Asset Resilience Ratio

Latest as of June 2023: 0.31%

Clinical Laserthermia Systems AB (publ) asset resilience ratio. Clinical Laserthermia Systems AB (publ) (CLS-B) has an Asset Resilience Ratio of 0.31% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CLS-B cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Skr139.00K
≈ $14.96K USD Cash + Short-term Investments

Total Assets

Skr44.47 Million
≈ $4.79 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Clinical Laserthermia Systems AB (publ) (2017–2022)

Asset resilience ratio of Clinical Laserthermia Systems AB (publ) from 2017 to 2022. This chart shows how Clinical Laserthermia Systems AB (publ)'s Asset Resilience Ratio has changed over time. Read total liabilities of Clinical Laserthermia Systems AB (publ) for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Clinical Laserthermia Systems AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Clinical Laserthermia Systems AB (publ) assets under control.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Skr0.00 0%
Short-term Investments Skr139.00K 0.31%
Total Liquid Assets Skr139.00K 0.31%

Asset Resilience Insights

  • Limited Liquidity: Clinical Laserthermia Systems AB (publ) maintains only 0.31% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Clinical Laserthermia Systems AB (publ) Industry Peers by Asset Resilience Ratio

Compare Clinical Laserthermia Systems AB (publ)'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Double Medical Technology Inc
SHE:002901
Medical Devices 12.59%
BMC Medical Co. Ltd. A
SHE:301367
Medical Devices 44.96%
Emvision Medical Devices Ltd
AU:EMV
Medical Devices 0.06%
Hironic Co. Ltd
KQ:149980
Medical Devices 17.42%
DRGEM Corporation
KQ:263690
Medical Devices 2.12%
Oncosil Medical Ltd
AU:OSL
Medical Devices 0.00%
Adherium Ltd
AU:ADR
Medical Devices 15.45%

Clinical Laserthermia Systems AB (publ) Asset Resilience Ratio by Year (2017–2022)

Clinical Laserthermia Systems AB (publ) asset resilience ratio by year from 2017 to 2022. The table below shows the annual Asset Resilience Ratio data for Clinical Laserthermia Systems AB (publ).

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-12-31 0.28% Skr139.49K
≈ $15.01K
Skr49.51 Million
≈ $5.33 Million
-43.86pp
2021-12-31 44.14% Skr29.46 Million
≈ $3.17 Million
Skr66.74 Million
≈ $7.18 Million
+18.74pp
2020-12-31 25.40% Skr11.28 Million
≈ $1.21 Million
Skr44.40 Million
≈ $4.78 Million
+16.07pp
2019-12-31 9.32% Skr3.60 Million
≈ $387.93K
Skr38.67 Million
≈ $4.16 Million
-31.96pp
2018-12-31 41.28% Skr23.95 Million
≈ $2.58 Million
Skr58.02 Million
≈ $6.24 Million
+10.97pp
2017-12-31 30.31% Skr13.62 Million
≈ $1.47 Million
Skr44.94 Million
≈ $4.84 Million
--
pp = percentage points

About Clinical Laserthermia Systems AB (publ)

ST:CLS-B Sweden Medical Devices
Market Cap
$9.27 Million
Skr86.16 Million SEK
Market Cap Rank
#27130 Global
#586 in Sweden
Share Price
Skr1.78
Change (1 day)
-0.22%
52-Week Range
Skr1.73 - Skr9.95
All Time High
Skr1089.26
About

Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control trea… Read more